Evaluation of 2′-Deoxy-2′-flouro-5-methyl-1-β-d-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo

Molecular Imaging

Volumn 1, Issue 2, 2002, Pages 74-81

  Alauddin, Mian M ^b   Shahinian, Atranik ^b   Gordon, Erlinda M ^b   Conti, Peter S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

FMAU; Gene expression; HSV tk; HT 29 cells; PET

Indexed keywords

CELLS; IMAGING TECHNIQUES; POSITRON EMISSION TOMOGRAPHY; PROTEINS; TUMORS;

RADIOTRACERS;

GENES;

2'-FLUORO-5-METHYLARABINOSYLURACIL; CARBON; CLEVUDINE; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; RECOMBINANT PROTEIN; THYMIDINE KINASE; URACIL ARABINOSIDE;

ANIMAL; ARTICLE; BIOTRANSFORMATION; CANCER TRANSPLANTATION; CELL CULTURE; COLON TUMOR; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HERPES SIMPLEX VIRUS 1; HUMAN; ISOTOPE DILUTION ASSAY; KINETICS; METABOLISM; MOUSE; NUDE MOUSE; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL; XENOGRAFT;

ANIMALS; ARABINOFURANOSYLURACIL; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CARBON RADIOISOTOPES; COLONIC NEOPLASMS; HERPESVIRUS 1, HUMAN; HUMANS; INDICATORS AND REAGENTS; KINETICS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOISOTOPE DILUTION TECHNIQUE; RECOMBINANT PROTEINS; THYMIDINE KINASE; TISSUE DISTRIBUTION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0042473079     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535002320162723     Document Type: Article

References (39)

1. Urbain JC (2001). Reporter genes and imaging. J Nucl Med. 42:106-109.
2. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wo L, Green LA, Bauer L, Maclaren DC, Nguyen K, Berk AJ, Cherry SR, Herschman HR (1999). Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography, Pro Natl Acad Sci USA. 2333-2338.
3. Gambhir SS, Barrio JR, Herschman HR, Phelps ME (1999). Assays for non-invasive imaging of reporter gene expression. Nucl Med Biol. 26:481-490.
4. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, Safer M, Beattie B, Diresta G, Dashigian F, Augensen F, Koutcher J, Sweit J, Human J, Larson SM, Finn R, Blasberg RG (1998). Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58:4333-4341.
5. Tjuvajev JG, Chen SH, Joshi A, Joshi R, Guo ZS, Balatoni J, Ballon D, Koutcher J, Finn R, Woo SL, Blasberg RG (1999). Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59:5186-5193.
6. Culver KW, Ram Zvi, Wallbridge S, Ishi H, Oldfleld EH, Blaese RM (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1550-1552.
7. Moolten FL, Wells JM, Heyman RA, Evans RM (1990). Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Hum Gene Ther. 1:125-134.
8. Oldfield EH, Ram Zvi, Culver K, Blease RM, DeVroom HL, Anderson WF (1993). Clinical protocols: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther. 4:39-69.
9. Ram Zvi, Culver KW, Oshireo EM, Viola JJ, DeVroom HL, Otto E, Chiang Y, McGarrity GJ, Muul LM, Kartz D, Blease RM, Oldfield EH (1997). Therapy of malignant brain tumors by intratumoral implantation of retroviral vector producing cells. Nat Med. 3:1353-1361.
10. Haberkorn U, Altmann A, Morr I, Knopf K, Germann C, Haeckel R, Oberdorfer F, Kaick G (1997). Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: Uptake of specific substrates. J Nucl Med. 38:287-294.
11. Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG (2001). Positron emission tomography-based imaging of transgene expression mediated by replication conditional, oncolytic herpes simplex virus type-1 mutant vectors of cancer. Cancer Res. 61:2983-2995.
12. Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Namavari M, Cherry SR, Phelps ME, Herschman HR, Gambhir SS (2000). Quantification of gene expression by imaging reporter gene expression in living animals. Nat Med. 6:933-937.
13. Tjuvajev JG, Stockhammar G, Desai R, Uehera H, Watanabe K, Gansbacher B, Blasberg RG (1995). Imaging the expression of transfected genes in vivo. Cancer Res. 55:6126-6132.
14. 18F]-FHBG) as a probe for PET imaging of gene expression in tumor-bearing nude mice. Anticancer Res. 18:4992-4993.
15. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol. 26:371-376.
16. Barrio JR, Namavari M, Satyamurthy N, Srinivasan A, Herschman HR, Gambhir SS, Cherry S, Phelps ME (1996). 8-[F-18]fluoroacyclovir: An in vivo probe for gene expression with PET. J Nucl Med. 37:193p.
17. 18F]-Fluoropenciclovir: An improved reporter probe for imaging HSV-tk reporter gene expression in vivo using PET. J Nucl Med. 42:96-105.
18. Spadari S, Maga G, Focher F, Ciarrocchi G, Manservigi R, Arcamone F, Capobianco M, Carcuro A, Colonna F, Iotti S, Garbesi A (1992). L-Thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. J Med Chem. 35:4214-4220.
19. 18F]FHPG): A potential imaging agent of viral infection and gene therapy using PET, Nucl Med Biol. 23:787-792.
20. 18F]-FHBG): A new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol. 25:175-180.
21. 18F]-FHBG) for in vivo measurement of suicide gene expression with PET. J Nucl Med. 42:1682-1690.
22. Yaghoubi SS, Goldman R, Barrio JR, Namavari M, Iyer M, Satyamurthy N, Herschman HR, Phelps ME, Gambhir SS (2000). PET imaging of FHBG in humans: A tracer for monitoring herpes simplex virus type 1 thymidine kinase suicide gene therapy. J Nucl Med. 41:73p.
23. 2: A facile entry for 8-fluoroguanine derivatives. J Org Chem. 61:6084-6085.
24. 18F]-fluoroguanine derivatives: In vivo probes for imaging gene expression with PET. Nucl Med Biol. 27:157-162.
25. 18F]-FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections. Nucl Med Biol. 27:113-119.
26. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Beatle B, Larson SM, Conti PS, Blasberg RG (2001). Direct comparison of HSV-tk PET imaging probes: FIAU, FHPG, FHBG. J Nucl Med 42:277p.
27. Deng WP, Peng CJ, Wu YW, Chang CW, Yu HM, Liu RS, Lin WJ (2001). Non-invasive gene probe in HSV-1 thymidine kinase gene therapy model J Nucl Med 42:276p.
28. Jong MDe, Nanda D, Bijster M, Weibi L, Bakker WH, Smith PA (2001). Imaging expression of the HSV-tk suicide gene using the nucleoside analogue FIRU. J Nucl Med. 42:277p.
29. Lee TS, Choi TH, Ahn SH, Woo KS, Jung WS, Lee SJ, Lim SJ, Choi CW, Lik SM (2001). Application of radioiodinated IVDU and IVFRU as gene therapy monitoring agents in HSV-tk gene transduced hepatocellular carcinoma (HCC) bearing Buffalo rats. J Nucl Med. 42:277p.
30. Weibe LI, Knaus EE, Morin KW (1999). Radiolabeled pyrimidine nucleosides to monitor the gene expression of HSV-1 thymidine kinase in gene therapy. Nucleosides Nucleotides. 18:1065-1066.
31. Morin KW, Atrazheva ED, Knaus EE, Weibe LI (1997). Synthesis and cellular uptake of 2′-substituted analogues of (E)-5(2-[125]iodovinyl-2-deoxyuridine in tumor cells transduced with herpes simplex virus type-1 thymidine kinase gene, Evaluation as probes for monitoring gene therapy. J Med Chem. 40:2184-2190.
32. 11C]-FMAU): A potential nucleoside analogue for in vivo study of cellular proliferation with PET. Nucl Med Biol. 22:783-789.
33. Conti PS, Anderson JH, Wong DF, Bading JR, Alauddin MM, Ravert HT, Mathews WB, Musachio JL, Dannals RF, Scheffel U (1996). Pre-clinical studies of 2′-fluoro-5-[C-11]-methyl-l-β-D-arabinofuranosylurcil (FMAU): A potential PET indicator of tumor proliferation. J Nucl Med. 37:107p.
34. 11C]-FMAU) indicates brain tumor growth rate in dogs. J Nucl Med. 42:83p.
35. 18F]-FMAU). J Labelled Comp Radiopharm. 45:1-8.
36. Lyons RM, Forry-Schaudies S, Otto E, Wey C, Patilkoota V, Kaloss M, McGarrity GJ, Chiang YL (1995). An improved retroviral vector encoding the herpes simplex virus thymidine kinas gene increasing antitumor efficacy in vivo. Cancer Gene Ther. 2:273-280.
37. Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D (1998). Mechanism for ganciclovir resistance in gastrointestinal tumor cells transduced with retroviral vector containing the herpes simplex virus thymidine kinase gene. Clin Cancer Res. 4:731-741.
38. 14C]-FMAU) in rat prostate tumor cells. Nucl Med Biol. 27:361-368.
39. Watanabe KA, Richmond W, Hirota K, Lopez C, Fox JJ (1979). Nucleosides 110. Synthesis and herpes virus activity of some 2′-fluoro-2′-deoxyarabinofuranosyl pyrimidine nucleosides. J Med Chem. 22:21-24.